Clinical Trial Update: Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy

View source ↗

Summary

A Bayer-sponsored clinical trial is recruiting to evaluate hydrotalcite for relief of acid symptoms caused by acid rebound after stopping long-term proton pump …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Hydrotalcite (hydrotalcite)

Snippet

Sponsor: Bayer | Conditions: Gastroesophageal Reflux | Status: RECRUITING